Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Opioid-sparing effects of medical cannabis or cannabinoids for chronic pain: a systematic review and meta-analysis of randomised and observational studies.

< BACK TO ARCHIVE


Papers: 24 Jul 2021 - 30 Jul 2021


Pharmacology/Drug Development


2021 Jul 28


BMJ Open


http://www.ncbi.nlm.nih.gov/pubmed/34321302?dopt=Abstract


11


7

Opioid-sparing effects of medical cannabis or cannabinoids for chronic pain: a systematic review and meta-analysis of randomised and observational studies.

Authors

Opioid-sparing effects of medical cannabis or cannabinoids for chronic pain: a systematic review and meta-analysis of randomised and observational studies.
Noori A, Miroshnychenko A, Shergill Y, Ashoorion V, Rehman Y, Couban RJ, Buckley ND, Thabane L, Bhandari M, Guyatt GH, Agoritsas T, Busse JW
BMJ Open. 2021 Jul 28; 11(7):e047717.
PMID: 34321302.

Abstract

To assess the efficacy and harms of adding medical cannabis to prescription opioids among people living with chronic pain.
Read This Paper